Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Actovex versus Avonex in relapsing-remitting multiple sclerosis
IRCT2013020812398N1Phase 3Completed
- Sponsor
- Actoverco
- Start
- Oct 2011
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3 trial of interferon beta-1a in multiple sclerosis (MS) (2 arms), sponsored by Actoverco. Started Oct 2011; status: completed.
02
Drugs
interferon beta-1a
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on IRCT2013020812398N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2013020812398N1.